Aquestive Therapeutics, Inc. (AQST)
4.055
+0.08
(+2.14%)
USD |
NASDAQ |
Oct 27, 16:00
4.055
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Cash from Investing (Quarterly) : -0.212M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.212M |
| March 31, 2026 | -0.052M |
| December 31, 2025 | -0.085M |
| September 30, 2025 | -0.235M |
| June 30, 2025 | -0.107M |
| March 31, 2025 | -0.135M |
| December 31, 2024 | -0.015M |
| September 30, 2024 | -0.08M |
| June 30, 2024 | -0.035M |
| March 31, 2024 | -0.029M |
| December 31, 2023 | -0.016M |
| September 30, 2023 | -0.151M |
| June 30, 2023 | -0.826M |
| March 31, 2023 | -0.002M |
| December 31, 2022 | -0.026M |
| September 30, 2022 | -1.717M |
| June 30, 2022 | -0.677M |
| March 31, 2022 | -0.104M |
| December 31, 2021 | -0.533M |
| Date | Value |
|---|---|
| September 30, 2021 | -0.083M |
| June 30, 2021 | -0.194M |
| March 31, 2021 | -0.103M |
| December 31, 2020 | -0.236M |
| September 30, 2020 | -0.038M |
| June 30, 2020 | -0.112M |
| March 31, 2020 | -0.131M |
| December 31, 2019 | -0.086M |
| September 30, 2019 | -0.091M |
| June 30, 2019 | -0.11M |
| March 31, 2019 | -0.376M |
| December 31, 2018 | -0.49M |
| September 30, 2018 | -0.448M |
| June 30, 2018 | -0.627M |
| March 31, 2018 | -0.259M |
| December 31, 2017 | -0.088M |
| September 30, 2017 | -0.433M |
| June 30, 2017 | -0.89M |
| March 31, 2017 | -0.657M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eton Pharmaceuticals, Inc. | 0.005M |
| LENZ Therapeutics, Inc. | 37.75M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.441M |
| Cash from Financing (Quarterly) | -2.591M |
| Free Cash Flow | -45.95M |
| Free Cash Flow Per Share (Quarterly) | -0.0772 |
| Free Cash Flow to Equity (Quarterly) | -25.16M |
| Free Cash Flow to Firm (Quarterly) | -5.813M |
| Free Cash Flow Yield | -9.44% |